The Fetal EKG Study
1 other identifier
observational
900
1 country
1
Brief Summary
The objective is to contribute data to ongoing research activities focused on identification of EKG waveform changes in the context of clinical conditions and maternal medication use. Additionally, to develop the capacity to measure contractions more accurately and more reliably using skin-surface electrodes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 16, 2014
CompletedFirst Posted
Study publicly available on registry
December 19, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedNovember 16, 2021
November 1, 2021
10.2 years
December 16, 2014
November 12, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quantitative FHR
Quantitative analysis of fetal heart-rate data recorded during labor using advanced mathetmatical techniques, including pattern-recognition analysis using EKG electrodes applied to the maternal abdomen.
During Labor
Secondary Outcomes (1)
Uterine contractions
During labor
Study Arms (1)
Women in labor
Pregnant women, women in labor, and women who are admitted to labor and delivery for scheduled c-sections will form the eligible population for recruitment into our study.
Interventions
Use of a system that monitors fetal heart rate through use of fetal EKG read using abdominal electrodes
Eligibility Criteria
Pregnant women, women in labor, and women who are admitted to labor and delivery for scheduled c-sections will form the eligible population for recruitment into our study. These women will be identified by a study staff-member who will ask on-call physicians, midwives, and nurses working on Labor and Delivery
You may qualify if:
- Women who are pregnant or in labor who are having their fetus' heart rate monitored continuously and able to consent
- years old or older.
- Gestational age of 24-42 weeks.
- Any method of fetal heart rate monitoring.
- Pregnant women in labor as well as women who are not in labor.
- Pregnant women who are admitted to labor and delivery for scheduled c-sections.
You may not qualify if:
- Women unable to consent
- Women under sedation or systemic anesthesia, and women who have diminished cognitive capacity
- Women in extremis (in severe pain, etc.)
- Women who are using the Mindchild device for clinical monitoring.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
South Shore Hospital
South Weymouth, Massachusetts, 02190, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Adam Wolfberg, MD
South Shore Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 16, 2014
First Posted
December 19, 2014
Study Start
October 1, 2013
Primary Completion
December 1, 2023
Study Completion
December 1, 2023
Last Updated
November 16, 2021
Record last verified: 2021-11